Clinical Trials Logo

Malignant Hemopathies clinical trials

View clinical trials related to Malignant Hemopathies.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02140736 Completed - Solid Tumors Clinical Trials

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

ORHEO
Start date: September 2009
Phase:
Study type: Observational

The main aim of this study is to observe correction of the hemoglobin level in the patients under chemotherapy, treated with epoetin alfa biosimilar and presenting with a solid tumor or a lymphoma or a myeloma.